HYPERCALCEMIA TREATMENT MARKET ANALYSIS

Hypercalcemia Treatment Market, by Drug Type (Bisphosphonates (Clodronate, Etidronate, Ibandronate, Pamidronate, and Zoledronic Acid), Calcitonin, Glucocorticoids, Denosumab, Calcimimetics, and Others), by Indication (Primary Hyperthyroidism, Hypercalcemia of Malignancy, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Mar 2022
Code : CMI3504
Pages :219
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key Players

Major players operating in the global hypercalcemia treatment market include Bayer AG, Pfizer, Inc., Novartis AG, Dr. Reddy’s Laboratories Ltd., Amgen Inc., Viatris Inc. (Mylan N.V.), Sun Pharmaceutical Industries Ltd., Cipla Inc., Actiza Pharmaceutical Pvt. Ltd., Apotex Inc., Crinetics Pharmaceuticals, Inc., Alkem Labs, Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals, and Slate Run Pharmaceuticals.